Order Article Reprints

Stokes ME, Surman MD, Calvo V, Surguladze D, Li A-H, Gasparek J, Betzenhauser M, Zhu G, Du H, Rigby AC, et al. Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors. Pharmaceutics. 2022; 14(10):2233. https://doi.org/10.3390/pharmaceutics14102233

Stokes, Michael E., Matthew D. Surman, Veronica Calvo, David Surguladze, An-Hu Li, Jennifer Gasparek, Matthew Betzenhauser, Guangyu Zhu, Hongwen Du, Alan C. Rigby, and et al. 2022. "Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors" Pharmaceutics 14, no. 10: 2233. https://doi.org/10.3390/pharmaceutics14102233

Stokes, M. E., Surman, M. D., Calvo, V., Surguladze, D., Li, A.-H., Gasparek, J., Betzenhauser, M., Zhu, G., Du, H., Rigby, A. C., & Mulvihill, M. J. (2022). Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors. Pharmaceutics, 14(10), 2233. https://doi.org/10.3390/pharmaceutics14102233